We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Nixes Single-Dose Premature Birth Prevention Medicine
FDA Nixes Single-Dose Premature Birth Prevention Medicine
The FDA has rejected a single-dose version of AMAG Pharmaceuticals’ hormone injection Makena, requesting additional information from the company before making a decision on the product.